165 related articles for article (PubMed ID: 25168308)
1. Repeated antigen painting and sublingual immunotherapy in mice convert sublingual dendritic cell subsets.
Zhang C; Ohno T; Kang S; Takai T; Azuma M
Vaccine; 2014 Sep; 32(43):5669-76. PubMed ID: 25168308
[TBL] [Abstract][Full Text] [Related]
2. Tolerogenic properties of CD206+ macrophages appeared in the sublingual mucosa after repeated antigen-painting.
Yang Y; Nagai S; Kang S; Xia Y; Kawano Y; Miyake K; Karasuyama H; Azuma M
Int Immunol; 2020 Jul; 32(8):509-518. PubMed ID: 32128565
[TBL] [Abstract][Full Text] [Related]
3. Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy.
Mitobe Y; Yokomoto Y; Ohashi-Doi K
Regul Toxicol Pharmacol; 2015 Apr; 71(3):529-40. PubMed ID: 25701184
[TBL] [Abstract][Full Text] [Related]
4. Update on immune mechanisms associated with sublingual immunotherapy: practical implications for the clinician.
Moingeon P
J Allergy Clin Immunol Pract; 2013; 1(3):228-41. PubMed ID: 24565479
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of co-signal molecules and migratory properties in four distinct subsets of migratory dendritic cells from the oral mucosa.
Aramaki O; Chalermsarp N; Otsuki M; Tagami J; Azuma M
Biochem Biophys Res Commun; 2011 Sep; 413(3):407-13. PubMed ID: 21893045
[TBL] [Abstract][Full Text] [Related]
6. Immunological mechanisms of sublingual allergen-specific immunotherapy.
Novak N; Bieber T; Allam JP
Allergy; 2011 Jun; 66(6):733-9. PubMed ID: 21251016
[TBL] [Abstract][Full Text] [Related]
7. Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells.
Mascarell L; Lombardi V; Louise A; Saint-Lu N; Chabre H; Moussu H; Betbeder D; Balazuc AM; Van Overtvelt L; Moingeon P
J Allergy Clin Immunol; 2008 Sep; 122(3):603-9.e5. PubMed ID: 18774396
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
[TBL] [Abstract][Full Text] [Related]
9. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen.
Yamanaka K; Shah SA; Sakaida H; Yamagiwa A; Masuda S; Mizutani H; Takeuchi K
Allergol Int; 2015 Jan; 64(1):54-9. PubMed ID: 25605528
[TBL] [Abstract][Full Text] [Related]
10. Long-term sublingual immunotherapy for Japanese cedar pollinosis and the levels of IL-17A and complement components 3a and 5a.
Sakashita M; Yamada T; Imoto Y; Hirota T; Tamari M; Ito Y; Kubo S; Osawa Y; Takahashi N; Fujieda S
Cytokine; 2015 Sep; 75(1):181-5. PubMed ID: 25934649
[TBL] [Abstract][Full Text] [Related]
11. Allergen Stability and Immunological Reactivity during Co-dissolution and Incubation of House Dust Mite and Japanese Cedar Pollen SLIT-Tablets.
Watanabe A; Yamamoto T; Matsuhara H; Matsui H; Nakazawa H; Lund K; Ohashi-Doi K
Biol Pharm Bull; 2020 Oct; 43(10):1448-1450. PubMed ID: 32759600
[TBL] [Abstract][Full Text] [Related]
12. Effect of Japanese cedar-specific sublingual immunotherapy on allergen-specific TH2 cell counts in blood.
Nomura T; Suzuki M; Yokota M; Nakamura Y; Ozeki K; Ito Y; Tsuge I; Saitoh S
Ann Allergy Asthma Immunol; 2016 Jul; 117(1):72-78.e4. PubMed ID: 27156747
[TBL] [Abstract][Full Text] [Related]
13. Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells.
Mascarell L; Lombardi V; Zimmer A; Louise A; Tourdot S; Van Overtvelt L; Moingeon P
Clin Exp Allergy; 2009 Dec; 39(12):1910-9. PubMed ID: 19694757
[TBL] [Abstract][Full Text] [Related]
14. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.
Calderón MA; Simons FE; Malling HJ; Lockey RF; Moingeon P; Demoly P
Allergy; 2012 Mar; 67(3):302-11. PubMed ID: 22150126
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells in distinct oral mucosal tissues engage different mechanisms to prime CD8+ T cells.
Nudel I; Elnekave M; Furmanov K; Arizon M; Clausen BE; Wilensky A; Hovav AH
J Immunol; 2011 Jan; 186(2):891-900. PubMed ID: 21160044
[TBL] [Abstract][Full Text] [Related]
16. Enhancing Allergen-Presentation Platforms for Sublingual Immunotherapy.
Moingeon P; Lombardi V; Baron-Bodo V; Mascarell L
J Allergy Clin Immunol Pract; 2017; 5(1):23-31. PubMed ID: 28065340
[TBL] [Abstract][Full Text] [Related]
17. Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen.
Ueda S; Ito J; Harada N; Harada S; Sasano H; Sandhu Y; Tanabe Y; Abe S; Shiota S; Kodama Y; Nagaoka T; Makino F; Chiba A; Akiba H; Atsuta R; Miyake S; Takahashi K
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454107
[TBL] [Abstract][Full Text] [Related]
18. Local immunological mechanisms of sublingual immunotherapy.
Allam JP; Novak N
Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):571-8. PubMed ID: 22001742
[TBL] [Abstract][Full Text] [Related]
19. Mucosal immunity and sublingual immunotherapy in respiratory disorders.
Vitaliti G; Leonardi S; Miraglia Del Giudice M; Salpietro A; Artusio L; Caimmi D; Arrigo T; Salpietro C; Ciprandi G; La Rosa M
J Biol Regul Homeost Agents; 2012; 26(1 Suppl):S85-93. PubMed ID: 22691255
[TBL] [Abstract][Full Text] [Related]
20. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis].
Yuta A; Miyamoto Y; Ogihara H; Hattori R; Okubo K
Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
